Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Thoracic 1 Other 1 NET 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1 CNS 1

Conditions

Colorectal Neoplasms 1

Interventions

Fluorouracil 616 Oxaliplatin 579 Gemcitabine 492 Capecitabine 445 Leucovorin 427 Irinotecan 390 Bevacizumab 331 Cisplatin 320 Radiotherapy 245 Cetuximab 215 Sorafenib 167 pembrolizumab 152 Docetaxel 150 Paclitaxel 140 Nivolumab 128 Albumin-Bound Paclitaxel 108 130-nm albumin-bound paclitaxel 108 Folfox protocol 101 Panitumumab 95 Erlotinib Hydrochloride 95 Surgical Procedures, Operative 86 regorafenib 84 S 1 (combination) 81 Drug Therapy 80 Radiation 69 Carboplatin 65 Neoadjuvant Therapy 64 Colonoscopy 64 Radiosurgery 63 Surveys and Questionnaires 60

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × RRx-001 × Gastrointestinal × Clear all

NCT02096354 2024-10-15

ROCKET

EpicentRx, Inc.

Phase 2 Completed

62 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡